WHO. GUIDELINES FOR THE PREVENTION, CARE AND TREATMENT OF PERSONS WITH CHRONIC HEPATITIS B INFECTION. World Health Organization. 19 March 2015. Available from: https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hepatitis/treatment-care/treatment-hbv. Cited 15 Febuary 2021.

View in Article Google ScholarNgui S.L. Andrews N.J. Underhill G.S. et al.

Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors.

Clin Infect Dis. 1998; 27: 100-106View in Article Google ScholarBrown Jr., R.S. McMahon B.J. Lok A.S. et al.

Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis.

Hepatology. 2016; 63: 319-333View in Article Google ScholarLi Z. Duan X. Hu Y. et al.

Efficacy and Safety of Lamivudine or Telbivudine in Preventing Mother-to-Child Transmission of Hepatitis B Virus: A Real-World Study.

Biomed Res Int. 2020; 2020: 1374276View in Article Google ScholarGreenup A.J. Tan P.K. Nguyen V. et al.

Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus.

J Hepatol. 2014; 61: 502-507View in Article Google ScholarLiu J. Wang J. Yan T. et al.

Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice.

J Viral Hepat. 2019; 26: 1170-1177View in Article Google ScholarPan C.Q. Duan Z. Dai E. et al.

Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.

N Engl J Med. 2016; 374: 2324-2334View in Article Google ScholarKim H.Y. Choi J.Y. Park C.H. et al.

Outcome after discontinuing antiviral agents during pregnancy in women infected with hepatitis B virus.

J Clin Virol. 2013; 56: 299-305View in Article Google ScholarChang C.Y. Aziz N. Poongkunran M. et al.

Serum Aminotransferase Flares in Pregnant and Postpartum Women With Current or Prior Treatment for Chronic Hepatitis B.

J Clin Gastroenterol. 2018; 52: 255-261View in Article Google ScholarYi W. Liu M. Cai H.D.

Safety of lamivudine treatment for chronic hepatitis B in early pregnancy.

World J Gastroenterol. 2012; 18: 6645-6650View in Article Google ScholarShang J. Wen Q. Wang C.C. et al.

Safety and efficacy of telbivudine for chronic hepatitis B during the entire pregnancy: Long-term follow-up.

J Viral Hepat. 2017; 24: S43-S48View in Article Google ScholarYi W. Li M.H. Xie Y. et al.

Prospective cohort study on the efficacy and safety of telbivudine used throughout pregnancy in blocking mother-to-child transmission of hepatitis B virus.

J Viral Hepat. 2017; 24: S49-S56View in Article Google ScholarGao X. Duan X. Cai H. et al.

The safety and efficacy of tenofovir disoproxil fumarate used throughout pregnancy for mothers with chronic hepatitis B.

Eur J Gastroenterol Hepatol. 2020; 32: 1533-1537View in Article Google ScholarChen H.L. Lee C.N. Chang C.H. et al.

Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus.

Hepatology. 2015; 62: 375-386View in Article Google ScholarFunk A.L. Lu Y. Yoshida K. et al.

Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.

Lancet Infect Dis. 2021; 21: 70-84View in Article Google ScholarEuropean Association for the Study of the Liver

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.

J Hepatol. 2017; 67: 370-398View in Article Google ScholarTerrault N.A. Lok A.S.F. McMahon B.J. et al.

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Hepatology. 2018; 67: 1560-1599View in Article Google ScholarHan G.R. Cao M.K. Zhao W. et al.

A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.

J Hepatol. 2011; 55: 1215-1221View in Article Google ScholarLiu J. Chen T. Chen Y. et al.

2019 Chinese Clinical Practice Guidelines for the Prevention of Mother-to-child Transmission of Hepatitis B Virus.

J Clin Transl Hepatol. 2020; 8: 397-406View in Article Google ScholarFaul F. Erdfelder E. Lang A.G. et al.

G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences.

Behav Res Methods. 2007; 39: 175-191View in Article Google ScholarSun W. Zhao S. Ma L. et al.

Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission.

BMC Gastroenterol. 2017; 17: 51View in Article Google ScholarSamadi Kochaksaraei G. Castillo E. Sadler M.D. et al.

Real-world clinical and virological outcomes in a retrospective multiethnic cohort study of 341 untreated and tenofovir disoproxil fumarate-treated chronic hepatitis B pregnant patients in North America.

Aliment Pharmacol Ther. 2020; 52: 1707-1716View in Article Google ScholarGiles M.L. Davey M.A. Wallace E.M.

Chronic hepatitis B infection and the risk of gestational diabetes: a cross-sectional study.

BJOG. 2020; 127: 1147-1152View in Article Google ScholarLiu M. Cai H. Yi W.

Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy.

J Viral Hepat. 2013; 20: S65-S70View in Article Google ScholarPan X. Chen J. Zhou L. et al.

Efficacy and safety of continuous antiviral therapy from preconception to prevent perinatal transmission of hepatitis B virus.

Sci Rep. 2020; 10: 13631View in Article Google Scholar

Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral Pregnancy Registry Interim Report for 1 January 1989 through 31 July 2020. Available from: http://apregistry.com/forms/exec-summary.pdf. Cited 20 Febuary 2021.

View in Article Google Scholar

National Health and Family Planning Commission. National comprehensive prevention and control program for birth defects. Available from: http://www.nhc.gov.cn/jkfpwlz/gzdt1ur/201902/ 97b46d93709a4333b90249d50e9c553c.shtml. Cited 20 February 2021.

View in Article Google ScholarGiles M. Visvanathan K. Lewin S. et al.

Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis B.

Gut. 2015; 64: 1810-1815View in Article Google ScholarBzowej N.H. Tran T.T. Li R. et al.

Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study.

Am J Gastroenterol. 2019; 114: 1283-1291View in Article Google ScholarChang C.Y. Aziz N. Poongkunran M. et al.

Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B.

Am J Gastroenterol. 2016; 111: 1410-1415View in Article Google ScholarLiu J. Wang J. Jin D. et al.

Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic hepatitis B virus.

J Gastroenterol Hepatol. 2017; 32: 177-183View in Article Google ScholarKushner T. Shaw P.A. Kalra A. et al.

Incidence, determinants and outcomes of pregnancy-associated hepatitis B flares: A regional hospital-based cohort study.

Liver Int. 2018; 38: 813-820View in Article Google Scholar